Advanced search
Publication Cover
Nanomedicine Volume 8, 2013 - Issue 7
Submit an article Journal homepage
263
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Taxol®-Induced Phosphatidylserine Exposure and Microvesicle Formation in Red Blood Cells Is Mediated by its Vehicle Cremophor® El

Pieter Vader1 Department of Clinical Chemistry & Hematology, University Medical Center Utrecht, Utrecht, The NetherlandsView further author information
,
Marcel HAM Fens1 Department of Clinical Chemistry & Hematology, University Medical Center Utrecht, Utrecht, The Netherlands;2 Children‘s Hospital Oakland Research Institute, Oakland, CA, USAView further author information
,
Nikoleta Sachini1 Department of Clinical Chemistry & Hematology, University Medical Center Utrecht, Utrecht, The NetherlandsView further author information
,
Brigitte A van Oirschot1 Department of Clinical Chemistry & Hematology, University Medical Center Utrecht, Utrecht, The NetherlandsView further author information
,
Grietje Andringa1 Department of Clinical Chemistry & Hematology, University Medical Center Utrecht, Utrecht, The NetherlandsView further author information
,
Antoine CG Egberts3 Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The NetherlandsView further author information
,
Carlo AJM Gaillard4 Department of Nephrology, Vrije Universiteit University Medical Center, Amsterdam, The NetherlandsView further author information
,
Jan T Rasmussen5 Protein Chemistry Laboratory, Department of Molecular Biology, Aarhus University, Aarhus, DenmarkView further author information
,
Richard van Wijk1 Department of Clinical Chemistry & Hematology, University Medical Center Utrecht, Utrecht, The NetherlandsView further author information
,
Wouter W van Solinge1 Department of Clinical Chemistry & Hematology, University Medical Center Utrecht, Utrecht, The NetherlandsView further author information
&
Raymond M Schiffelers1 Department of Clinical Chemistry & Hematology, University Medical Center Utrecht, Utrecht, The NetherlandsCorrespondence[email protected]
View further author information
 show all
Pages 1127-1135 | Received 16 Apr 2012, Accepted 24 Aug 2012, Published online: 25 Jun 2013

References

  • Schiff PB , FantJ, HorwitzSB. Promotion of microtubule assembly in vitro by Taxol. Nature277(5698), 665–667 (1979).
  • Weiss RB , DonehowerRC, WiernikPHet al. Hypersensitivity reactions from taxol. J. Clin. Oncol. 8(7), 1263–1268 (1990).
  • Grem JL , TutschKD, SimonKJet al. Phase I study of taxol administered as a short i.v. infusion daily for 5 days. Cancer Treat. Rep. 71(12), 1179–1184 (1987).
  • Rowinsky EK , BurkePJ, KarpJE, TuckerRW, EttingerDS, DonehowerRC. Phase I and pharmacodynamic study of taxol in refractory acute leukemias. Cancer Res.49(16), 4640–4647 (1989).
  • Chen YM , PerngRP, LeeYCet al. Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized Phase II study of combination chemotherapy against inoperable nonsmall-cell lung cancer previously untreated. Ann. Oncol. 13(1), 108–115 (2002).
  • Kourousis C , KakolyrisS, AndroulakisNet al. Salvage chemotherapy with paclitaxel, vinorelbine, and cisplatin (PVC) in anthracycline-resistant advanced breast cancer. Am. J. Clin. Oncol. 21(3), 226–232 (1998).
  • Rowinsky EK , McguireWP, GuarnieriT, FishermanJS, ChristianMC, DonehowerRC. Cardiac disturbances during the administration of taxol. J. Clin. Oncol.9(9), 1704–1712 (1991).
  • Arbuck SG , StraussH, RowinskyEet al. A reassessment of cardiac toxicity associated with Taxol. J. Natl Cancer Inst. Monogr. (15), 117–130 (1993).
  • Lang PA , HuoberJ, BachmannCet al. Stimulation of erythrocyte phosphatidylserine exposure by paclitaxel. Cell Physiol. Biochem. 18 (1–3), 151–164 (2006).
  • Wilson NM , EspiritoJL, ValeroV, PusztaiL. Paclitaxel-induced sickle cell crisis. Am. J. Health Syst. Pharm.65(14), 1333–1336 (2008).
  • Hvarregaard J , AndersenMH, BerglundL, RasmussenJT, PetersenTE. Characterization of glycoprotein PAS-6/7 from membranes of bovine milk fat globules. Eur. J. Biochem.240(3), 628–636 (1996).
  • Salzer U , HinterdorferP, HungerU, BorkenC, ProhaskaR. Ca(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Blood99(7), 2569–2577 (2002).
  • Allan D , ThomasP, LimbrickAR. The isolation and characterization of 60 nm vesicles (‘nanovesicles‘) produced during ionophore A23187-induced budding of human erythrocytes. Biochem. J.188(3), 881–887 (1980).
  • Liu C , YuS, ZinnKet al. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J. Immunol. 176(3), 1375–1385 (2006).
  • Sparreboom A , LoosWJ, VerweijJet al. Quantitation of Cremophor EL in human plasma samples using a colorimetric dye-binding microassay. Anal. Biochem. 255(2), 171–175 (1998).
  • Sparreboom A , Van Tellingen O, Nooijen WJ, Beijnen JH. Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL. Cancer Res.56(9), 2112–2115 (1996).
  • Connor J , PakCC, SchroitAJ. Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells. J. Biol. Chem.269(4), 2399–2404 (1994).
  • Boas FE , FormanL, BeutlerE. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc. Natl Acad. Sci. USA95(6), 3077–3081 (1998).
  • Ten Tije AJ , LoosWJ, VerweijJet al. Disposition of polyoxyethylated excipients in humans: implications for drug safety and formulation approaches. Clin. Pharmacol. Ther. 74(5), 509–510 (2003).
  • Closse C , Dachary-PrigentJ, BoisseauMR. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br. J. Hematol.107(2), 300–302 (1999).
  • Fens MH , Van Wijk R, Andringa G et al. A role for activated endothelial cells in red blood cell clearance: implications for vasopathology. Hematologica97(4), 500–508 (2011).
  • Hanayama R , TanakaM, MiwaK, ShinoharaA, IwamatsuA, NagataS. Identification of a factor that links apoptotic cells to phagocytes. Nature417(6885), 182–187 (2002).
  • Wu Y , TibrewalN, BirgeRB. Phosphatidylserine recognition by phagocytes: a view to a kill. Trends Cell Biol.16(4), 189–197 (2006).
  • Tissot JD , RubinO, CanelliniG. Analysis and clinical relevance of microparticles from red blood cells. Curr. Opin. Hematol.17(6), 571–577 (2010).
  • Kriebardis AG , AntonelouMH, StamoulisKE, Economou-PetersenE, MargaritisLH, PapassideriIS. RBC-derived vesicles during storage: ultrastructure, protein composition, oxidation, and signaling components. Transfusion48(9), 1943–1953 (2008).
  • Greenwalt TJ . The how and why of exocytic vesicles. Transfusion46(1), 143–152 (2006).
  • Del Conde I , ShrimptonCN, ThiagarajanP, LopezJA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood106(5), 1604–1611 (2005).
  • Al-Nedawi K , MeehanB, MicallefJet al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 10(5), 619–624 (2008).
  • Vanwijk MJ , VanbavelE, SturkA, NieuwlandR. Microparticles in cardiovascular diseases. Cardiovasc. Res.59(2), 277–287 (2003).
  • Lang F , LangKS, LangPA, HuberSM, WiederT. Mechanisms and significance of eryptosis. Antioxid. Redox Signal.8(7–8), 1183–1192 (2006).
  • Zwaal RF , SchroitAJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood89(4), 1121–1132 (1997).
  • Silvestre JS , TheryC, HamardGet al. Lactadherin promotes VEGF-dependent neovascularization. Nat. Med. 11(5), 499–506 (2005).
  • Hebbel RP , BoogaertsMA, EatonJW, SteinbergMH. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N. Engl. J. Med.302(18), 992–995 (1980).
  • Setty BN , KulkarniS, StuartMJ. Role of erythrocyte phosphatidylserine in sickle red cell–endothelial adhesion. Blood99(5), 1564–1571 (2002).
  • Pap E , PallingerE, PasztoiM, FalusA. Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm. Res.58(1), 1–8 (2009).
  • Simak J , GeldermanMP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus. Med. Rev.20(1), 1–26 (2006).
  • Iida K , WhitlowMB, NussenzweigV. Membrane vesiculation protects erythrocytes from destruction by complement. J. Immunol.147(8), 2638–2642 (1991).
  • Lion N , CrettazD, RubinO, TissotJD. Stored red blood cells: a changing universe waiting for its map(s). J. Proteomics73(3), 374–385 (2010).
  • Sadallah S , EkenC, SchifferliJA. Erythrocyte-derived ectosomes have immunosuppressive properties. J. Leukoc. Biol.84(5), 1316–1325 (2008).
  • Szebeni J , MuggiaFM, AlvingCR. Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. J. Natl Cancer Inst.90(4), 300–306 (1998).
  • Bosman GJ , LasonderE, LutenMet al. The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 48(5), 827–835 (2008).
  • Camussi G , DeregibusMC, BrunoS, CantaluppiV, BianconeL. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int.78(9), 838–848 (2010).
  • Ratajczak J , WysoczynskiM, HayekF, Janowska-WieczorekA, RatajczakMZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia20(9), 1487–1495 (2006).
  • Van Dommelen SM , VaderP, LakhalSet al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J. Control. Release 161(2), 635–644 (2011).
  • Sloand EM , MainwaringL, KeyvanfarKet al. Transfer of glycosylphosphatidylinositol-anchored proteins to deficient cells after erythrocyte transfusion in paroxysmal nocturnal hemoglobinuria. Blood 104(12), 3782–3788 (2004).
  • Gradishar WJ , TjulandinS, DavidsonNet al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J. Clin. Oncol. 23(31), 7794–7803 (2005).
  • Soga O , Van Nostrum CF, Fens M et al. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. J. Control. Release103(2), 341–353 (2005).
  • Ooya T , LeeJ, ParkK. Effects of ethylene glycol-based graft, star-shaped, and dendritic polymers on solubilization and controlled release of paclitaxel. J. Control. Release93(2), 121–127 (2003).
  • Biswas S , DodwadkarNS, DeshpandePP, TorchilinVP. Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium–PEG–PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. J. Control. Release159(3), 393–402 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.